LLS Research
More than $1.8 billion invested in cancer research since 1949
The Leukemia & Lymphoma Society is the largest nonprofit funder of leading-edge research for every type of blood cancer, including leukemia, lymphoma, myeloma, and other rare types of blood cancers.
We make thoughtful investments in blood cancer research that will lead to scientific breakthroughs that will improve and save the lives of patients.
The LLS Research Team oversees the organization's research agenda and manages our portfolio to support cutting-edge research for every type of blood cancer.
Who We Fund
We fund innovative blood cancer research. Meet our current awardees!
Research Programs
We award grants for studies that range from basic blood cancer research to clinical trials.
TAP
Therapy Acceleration Program
Ulrich G. Steidl, M.D., Ph.D.
Professor,
Director of Ruth L. and David S. Gottesman Institute for Stem Cell, Research & Regenerative Medicine, Albert Einstein College of Medicine
Featured Researcher
“I cannot overstate the impact that the LLS Scholar Award has had on my career and the research directions that my laboratory has engaged in. The award came at an absolutely critical time in my career and enabled me to significantly further develop and elevate my research program.”
- Ulrich G. Steidl, M.D., Ph.D.
2019 LLS-CDP SCHOLAR ACHIEVEMENT AWARD
Research News
There is always so much going on at LLS Research and in the world of blood cancers.
